Most men on TRT inject testosterone once a week, but the actual schedule ranges from every day to every 12 weeks depending on the type of testosterone prescribed. The FDA-approved label for testosterone cypionate, the most commonly used form in the United States, recommends injections every two to four weeks. In practice, many clinicians now prescribe weekly or twice-weekly injections to keep blood levels steadier.
Why the Type of Testosterone Matters
Testosterone is attached to different chemical “esters” that control how slowly it releases into your bloodstream after injection. The ester determines how long each shot lasts and, by extension, how often you need one.
- Testosterone propionate is a short-acting form that clears your system quickly, requiring injections once or twice per week.
- Testosterone enanthate has a half-life of about 4 to 5 days. It’s typically injected every one to two weeks.
- Testosterone cypionate has a half-life of 5 to 7 days and follows a similar schedule, usually weekly or every two weeks.
- Testosterone undecanoate is a long-acting option with a half-life of roughly 10 to 12 weeks. After an initial loading period, maintenance injections come every 10 to 12 weeks and must be given in a clinical setting.
Cypionate and enanthate are by far the most commonly prescribed in the U.S. and are functionally interchangeable for most patients. Undecanoate is less widely used, partly because of cost and partly because it requires an in-office injection due to a rare risk of a reaction that needs medical monitoring.
The Most Common Schedules
The FDA label for testosterone cypionate lists a dose of 50 to 400 mg every two to four weeks. That range is broad, and many prescribers have moved toward more frequent, smaller doses because they produce more stable testosterone levels. In one large clinical study tracking men on intramuscular testosterone, 83% were injecting every 7 days.
Here’s what the most popular schedules look like in practice:
- Every two weeks: A traditional schedule still used by some clinics. You inject a larger dose (often 200 mg) and wait 14 days. Levels peak within a few days and can drop noticeably before the next injection, which is why many men report feeling great the first week and sluggish the second.
- Once a week: The most widely used frequency today. A typical dose is 100 to 200 mg of cypionate or enanthate. Weekly shots reduce the gap between peak and trough levels, leading to fewer energy and mood swings.
- Twice a week: Splitting the weekly dose into two smaller injections (for example, 50 mg on Monday and 50 mg on Thursday). This narrows the peak-to-trough swing even further.
- Daily microdosing: Small daily injections, often subcutaneous, intended to mimic the body’s natural daily testosterone rhythm. This requires 365 injections per year and is the hardest schedule to maintain consistently.
How Injection Frequency Affects Your Levels
Even on a stable weekly schedule, testosterone levels are not perfectly consistent from one week to the next. Research published in The Journal of Urology tracked men injecting on a fixed weekly dose and found that peak levels averaged around 910 ng/dL while trough levels (the lowest point before the next injection) averaged about 558 ng/dL. That’s a swing of roughly 350 ng/dL within each cycle.
More surprising, the study showed significant variation between cycles. Peak levels shifted by an average of 23% from one week to the next, and trough levels varied by about 17.5%. A quarter of the men experienced peak swings greater than 50% and trough swings over 35%. So even with perfect timing and dosing, your levels will fluctuate more than most people expect. This is one reason clinicians look at trends across multiple blood draws rather than making big dose changes based on a single lab result.
Injecting more frequently (twice weekly or daily) does reduce the size of each peak-to-trough swing because each individual dose is smaller. Whether that translates to noticeably better symptom control varies from person to person.
Subcutaneous vs. Intramuscular Injections
Traditional TRT injections go into a large muscle, usually the glute or thigh. Subcutaneous injections, given into the fat just beneath the skin (typically the abdomen or thigh), have become increasingly popular because they use smaller needles and are easier to self-administer.
The injection frequency doesn’t change much between the two routes. Subcutaneous protocols typically use the same weekly schedule with cypionate or enanthate at doses of 50 to 100 mg per week. Studies in both hypogonadal and transgender men confirm that subcutaneous weekly injections produce physiological and predictable testosterone levels. For men who prefer less frequent dosing, the intramuscular route remains more common simply because larger volumes of oil are easier to inject into muscle than into subcutaneous fat.
Long-Acting Injections for Less Frequent Dosing
If weekly or biweekly injections feel like a burden, testosterone undecanoate offers a dramatically different schedule. After an initial loading phase (a first injection, a second at 4 to 6 weeks), you move to maintenance injections roughly every 10 to 12 weeks. In a study following 297 patients through over 6,300 injections, the optimal interval after individual dose adjustments settled at a median of 12 weeks, with about 70% of patients landing right at that 12-week mark.
A 10-year Korean observational study found that men on testosterone undecanoate had the highest treatment continuation rates of any TRT formulation: 90.8% were still on therapy after one year, compared to just 58% for men on testosterone enanthate injections given every few weeks. Among undecanoate users, not a single patient cited inconvenience as a reason for stopping. The main barrier was cost, which was the reason 68% of those who did discontinue gave for quitting.
Frequency and Side Effects
One of the most clinically relevant side effects of TRT is a rise in hematocrit, the percentage of your blood made up of red blood cells. Higher hematocrit thickens the blood and can increase cardiovascular risk. Research shows that hematocrit begins climbing within the first month of testosterone therapy and continues rising in a dose-dependent pattern over at least three months.
Interestingly, the mechanism involves estradiol, which testosterone is converted into by the body. Estradiol stimulates the bone marrow to produce more red blood cells. Because less frequent injections create higher peaks in testosterone (and therefore higher spikes in estradiol), they may drive hematocrit up more than smaller, more frequent doses that keep levels flatter. Transdermal formulations like gels and patches are associated with lower hematocrit elevations than injections for the same reason: they deliver testosterone more gradually.
This is one practical reason many clinicians now prefer weekly or twice-weekly protocols over every-two-week injections. Smaller, more frequent doses reduce the sharp hormonal peaks that contribute to red blood cell overproduction and estrogen-related side effects like water retention.
Choosing a Schedule That Sticks
The best injection frequency is the one you’ll actually follow consistently. Adherence matters more than theoretical perfection in hormone levels. Daily microdosing sounds appealing on paper, but 365 injections per year leaves far more room for missed or delayed doses. Clinicians who have tried daily protocols with patients report that most struggle with consistency over time, and the very small individual doses can mean slower initial symptom relief because each shot contributes so little on its own.
Weekly injections hit a practical sweet spot for most men: they’re frequent enough to maintain reasonably stable levels, infrequent enough to be easy to remember, and the dose per injection is large enough to produce noticeable effects relatively quickly. For men who find even weekly shots inconvenient, testosterone undecanoate’s 10 to 12 week cycle is the least demanding schedule available, though it requires office visits and tends to cost more.